<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:109px; width:137px; height:27px;"><span style="font-family: Arial,Bold; font-size:14px">FRIDAY, JUNE 12 
<br></span><span style="font-family: Arial,Bold; font-size:10px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:138px; width:0px; height:1px;"><span style="font-family: ABCDEE+Arial Bold,Bold; font-size:1px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:191px; top:142px; width:363px; height:163px;"><span style="font-family: Arial,Bold; font-size:11px">Thomas Linn, MD 
<br></span><span style="font-family: Arial; font-size:10px">Thomas Linn received his MD degree studying nutritional changes in the 
<br>lipid composition of red blood cells. He worked as a junior researcher at 
<br>Rudolf-Buchheim-Institute for Pharmacology, Giessen. Then he started 
<br>clinical training in internal medicine, endocrinology and metabolism 
<br>completing with board examination. He chose the field of experimental 
<br>diabetology for his main thesis working on the biology of pancreatic islets 
<br>and the role of inflammatory processes in the damage of insulin producing 
<br>cells. Since 1999 he is Head of Clinical Research Unit at Medical Clinic 3 
<br>of University Hospital, Giessen. In 2006 he accepted a call from Justus- 
<br>Liebig University to become Professor of Internal Medicine with focus on 
<br>the pathophysiology of metabolism and nutritional medicine. His research 
<br>is supported from different public and private sponsors; he is founding 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:307px; width:497px; height:200px;"><span style="font-family: Arial; font-size:10px">member of the Committee of Giessen Graduate School for the Life Sciences.</span><span style="font-family: Arial,Bold; font-size:10px"> 
<br></span><span style="font-family: Arial; font-size:10px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Slowly and rapidly absorbed carbohydrates on postprandial metabolism in type 2 
<br>diabetes  
<br></span><span style="font-family: Arial; font-size:10px">Isomaltulose (ISO) attenuates postprandial glucose responses compared to sucrose (SUC) in type 2 
<br>diabetes mellitus (T2DM). However, the mechanisms have not been studied. In a randomized 
<br>crossover study, eleven T2DM subjects underwent a euglycemic clamp combined with labeled oral 
<br>ISO and SUC load. Glucose kinetics were analyzed for a 4-h postprandial period. Following ISO 
<br>ingestion glucose absorption was prolonged (P = 0.005), mean plasma concentrations of insulin, C-
<br>peptide, glucagon, and GIP were ~9-17% lower (P &lt; 0.05), by contrast GLP-1 was ~55% higher (P &lt; 
<br>0.001) compared to SUC. Total amount of systemic glucose appearance was ~35% lower with ISO (P 
<br>&lt; 0.001) due to reduction of both endogenous and exogeneous glucose appearance and augmented 
<br>splanchnic uptake. Insulin action was increased after ISO compared to SUC (P = 0.028).  In 
<br>conclusion, slowly absorbed ISO reduced systemic incorporation of oral glucose by inhibiting glucose 
<br>production and enhancing splanchnic glucose uptake.  
<br> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:524px; width:491px; height:48px;"><span style="font-family: Arial; font-size:10px">1. Isomaltulose bolus is completely absorbed in patients with type 2 diabetes mellitus (T2DM) 
<br>2. Slow absorption of sugar reduces blood glucose levels via effects on splanchnic glucose turnover  
<br>3. Isomaltulose drink is associated with a favorable gut hormone profile for T2DM patient 
<br> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:252px; top:511px; width:110px; height:10px;"><span style="font-family: Arial,Bold; font-size:10px">Learning objectives: 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:200px; top:586px; width:9px; height:18px;"><span style="font-family: ABCDEE+MV Boli; font-size:18px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:586px; width:9px; height:18px;"><span style="font-family: ABCDEE+MV Boli; font-size:18px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">35 
<br> 
<br></span></div><span style="position:absolute; border: black 1px solid; left:50px; top:508px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:508px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:508px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:508px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:508px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:508px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:508px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:522px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:522px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:534px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:534px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:547px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:547px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:573px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:573px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:573px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:573px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:573px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:560px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:560px; width:0px; height:13px;"></span>
<div style="position:absolute; border: figure 1px solid; writing-mode:False; left:61px; top:143px; width:120px; height:153px;"></div><span style="position:absolute; border: black 1px solid; left:60px; top:143px; width:120px; height:153px;"></span>
<div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
